These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33258481)

  • 21. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.
    Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J
    Elife; 2023 Mar; 12():. PubMed ID: 36971353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features.
    Fitzgerald LM; Kwon EM; Koopmeiners JS; Salinas CA; Stanford JL; Ostrander EA
    Clin Cancer Res; 2009 May; 15(9):3231-7. PubMed ID: 19366831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic predisposition to prostate cancer.
    Benafif S; Eeles R
    Br Med Bull; 2016 Dec; 120(1):75-89. PubMed ID: 27941040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci.
    Amin Al Olama A; Benlloch S; Antoniou AC; Giles GG; Severi G; Neal DE; Hamdy FC; Donovan JL; Muir K; Schleutker J; Henderson BE; Haiman CA; Schumacher FR; Pashayan N; Pharoah PD; Ostrander EA; Stanford JL; Batra J; Clements JA; Chambers SK; Weischer M; Nordestgaard BG; Ingles SA; Sorensen KD; Orntoft TF; Park JY; Cybulski C; Maier C; Doerk T; Dickinson JL; Cannon-Albright L; Brenner H; Rebbeck TR; Zeigler-Johnson C; Habuchi T; Thibodeau SN; Cooney KA; Chappuis PO; Hutter P; Kaneva RP; Foulkes WD; Zeegers MP; Lu YJ; Zhang HW; Stephenson R; Cox A; Southey MC; Spurdle AB; FitzGerald L; Leongamornlert D; Saunders E; Tymrakiewicz M; Guy M; Dadaev T; Little SJ; Govindasami K; Sawyer E; Wilkinson R; Herkommer K; Hopper JL; Lophatonanon A; Rinckleb AE; Kote-Jarai Z; Eeles RA; Easton DF; ; ;
    Cancer Epidemiol Biomarkers Prev; 2015 Jul; 24(7):1121-9. PubMed ID: 25837820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Family History of Prostate and Breast Cancer Integrated with a Polygenic Risk Score Identifies Men at Highest Risk of Dying from Prostate Cancer before Age 75 Years.
    Plym A; Zhang Y; Stopsack KH; Jee YH; Wiklund F; Kibel AS; Kraft P; Giovannucci E; Penney KL; Mucci LA
    Clin Cancer Res; 2022 Nov; 28(22):4926-4933. PubMed ID: 36103261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast cancer risk prediction using a clinical risk model and polygenic risk score.
    Shieh Y; Hu D; Ma L; Huntsman S; Gard CC; Leung JW; Tice JA; Vachon CM; Cummings SR; Kerlikowske K; Ziv E
    Breast Cancer Res Treat; 2016 Oct; 159(3):513-25. PubMed ID: 27565998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Polygenic Risk Score for Breast Cancer in US Latinas and Latin American Women.
    Shieh Y; Fejerman L; Lott PC; Marker K; Sawyer SD; Hu D; Huntsman S; Torres J; Echeverry M; Bohórquez ME; Martínez-Chéquer JC; Polanco-Echeverry G; Estrada-Flórez AP; ; Haiman CA; John EM; Kushi LH; Torres-Mejía G; Vidaurre T; Weitzel JN; Zambrano SC; Carvajal-Carmona LG; Ziv E; Neuhausen SL
    J Natl Cancer Inst; 2020 Jun; 112(6):590-598. PubMed ID: 31553449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of novel genetic susceptibility loci for calcium-containing kidney stone disease by genome-wide association study and polygenic risk score in a Taiwanese population.
    Chen WC; Chen YC; Chen YH; Liu TY; Tsai CH; Tsai FJ
    Urolithiasis; 2024 Jun; 52(1):94. PubMed ID: 38896256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An early-onset specific polygenic risk score optimizes age-based risk estimate and stratification of prostate cancer: population-based cohort study.
    Cheng Y; Wu L; Xin J; Ben S; Chen S; Li H; Zhao L; Wang M; Cheng G; Du M
    J Transl Med; 2024 Apr; 22(1):366. PubMed ID: 38632662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Utility of Germline Genetic Testing in Japanese Men Undergoing Prostate Biopsy.
    Akamatsu S; Terada N; Takata R; Kinoshita H; Shimatani K; Momozawa Y; Yamamoto M; Tada H; Kawamorita N; Narita S; Kato T; Nitta M; Kandori S; Koike Y; Inazawa J; Kimura T; Kimura H; Kojima T; Terachi T; Sugimoto M; Habuchi T; Arai Y; Yamamoto S; Matsuda T; Obara W; Kamoto T; Inoue T; Nakagawa H; Ogawa O
    JNCI Cancer Spectr; 2022 Feb; 6(1):. PubMed ID: 35118230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polygenic Risk Scores for Prediction of Gastric Cancer Based on Bioinformatics Screening and Validation of Functional lncRNA SNPs.
    Duan F; Song C; Wang P; Ye H; Dai L; Zhang J; Wang K
    Clin Transl Gastroenterol; 2021 Nov; 12(11):e00430. PubMed ID: 34797779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No Association Between Polygenic Risk Scores for Cancer and Development of Radiation Therapy Toxicity.
    Barnett GC; Kerns SL; Dorling L; Fachal L; Aguado-Barrera ME; Martínez-Calvo L; Jandu HK; Welsh C; Tyrer J; Coles CE; Haviland JS; Parker C; Gómez-Caamaño A; Calvo-Crespo P; Sosa-Fajardo P; Burnet NG; Summersgill H; Webb A; De Ruysscher D; Seibold P; Chang-Claude J; Talbot CJ; Rattay T; Parliament M; De Ruyck K; Rosenstein BS; Pharoah PDP; Dunning AM; Vega A; West CML;
    Int J Radiat Oncol Biol Phys; 2022 Nov; 114(3):494-501. PubMed ID: 35840111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unidentified genetic variants influence pancreatic cancer risk: an analysis of polygenic susceptibility in the PanScan study.
    Pierce BL; Tong L; Kraft P; Ahsan H
    Genet Epidemiol; 2012 Jul; 36(5):517-24. PubMed ID: 22644738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CYP3A4 and VDR gene polymorphisms and the risk of prostate cancer in men with benign prostate hyperplasia.
    Tayeb MT; Clark C; Haites NE; Sharp L; Murray GI; McLeod HL
    Br J Cancer; 2003 Mar; 88(6):928-32. PubMed ID: 12644831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive value of polygenic risk score for prostate cancer incidence and prognosis in the Han Chinese.
    Hung SC; Chang LW; Hsiao TH; Wei CY; Wang SS; Li JR; Chen IC
    Sci Rep; 2024 Sep; 14(1):20453. PubMed ID: 39227454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetes genes and prostate cancer in the Atherosclerosis Risk in Communities study.
    Meyer TE; Boerwinkle E; Morrison AC; Volcik KA; Sanderson M; Coker AL; Pankow JS; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):558-65. PubMed ID: 20142250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin D receptor, HER-2 polymorphisms and risk of prostate cancer in men with benign prostate hyperplasia.
    Tayeb MT; Clark C; Haites NE; Sharp L; Murray GI; McLeod HL
    Saudi Med J; 2004 Apr; 25(4):447-51. PubMed ID: 15083213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry.
    Chen F; Madduri RK; Rodriguez AA; Darst BF; Chou A; Sheng X; Wang A; Shen J; Saunders EJ; Rhie SK; Bensen JT; Ingles SA; Kittles RA; Strom SS; Rybicki BA; Nemesure B; Isaacs WB; Stanford JL; Zheng W; Sanderson M; John EM; Park JY; Xu J; Wang Y; Berndt SI; Huff CD; Yeboah ED; Tettey Y; Lachance J; Tang W; Rentsch CT; Cho K; Mcmahon BH; Biritwum RB; Adjei AA; Tay E; Truelove A; Niwa S; Sellers TA; Yamoah K; Murphy AB; Crawford DC; Patel AV; Bush WS; Aldrich MC; Cussenot O; Petrovics G; Cullen J; Neslund-Dudas CM; Stern MC; Kote-Jarai Z; Govindasami K; Cook MB; Chokkalingam AP; Hsing AW; Goodman PJ; Hoffmann TJ; Drake BF; Hu JJ; Keaton JM; Hellwege JN; Clark PE; Jalloh M; Gueye SM; Niang L; Ogunbiyi O; Idowu MO; Popoola O; Adebiyi AO; Aisuodionoe-Shadrach OI; Ajibola HO; Jamda MA; Oluwole OP; Nwegbu M; Adusei B; Mante S; Darkwa-Abrahams A; Mensah JE; Diop H; Van Den Eeden SK; Blanchet P; Fowke JH; Casey G; Hennis AJ; Lubwama A; Thompson IM; Leach R; Easton DF; Preuss MH; Loos RJ; Gundell SM; Wan P; Mohler JL; Fontham ET; Smith GJ; Taylor JA; Srivastava S; Eeles RA; Carpten JD; Kibel AS; Multigner L; Parent MÉ; Menegaux F; Cancel-Tassin G; Klein EA; Andrews C; Rebbeck TR; Brureau L; Ambs S; Edwards TL; Watya S; Chanock SJ; Witte JS; Blot WJ; Michael Gaziano J; Justice AC; Conti DV; Haiman CA
    Eur Urol; 2023 Jul; 84(1):13-21. PubMed ID: 36872133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of a panel of 18 SNPs on breast cancer risk in women attending a UK familial screening clinic: a case-control study.
    Evans DG; Brentnall A; Byers H; Harkness E; Stavrinos P; Howell A; ; Newman WG; Cuzick J
    J Med Genet; 2017 Feb; 54(2):111-113. PubMed ID: 27794048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Refining the prostate cancer genetic association within the JAZF1 gene on chromosome 7p15.2.
    Prokunina-Olsson L; Fu YP; Tang W; Jacobs KB; Hayes RB; Kraft P; Berndt SI; Wacholder S; Yu K; Hutchinson A; Spencer Feigelson H; Thun MJ; Diver WR; Albanes D; Virtamo J; Weinstein S; Schumacher FR; Cancel-Tassin G; Cussenot O; Valeri A; Andriole GL; Crawford ED; Haiman CA; Henderson BE; Kolonel L; Le Marchand L; Siddiq A; Riboli E; Travis R; Kaaks R; Isaacs WB; Isaacs SD; Grönberg H; Wiklund F; Xu J; Vatten LJ; Hveem K; Kumle M; Tucker M; Hoover RN; Fraumeni JF; Hunter DJ; Thomas G; Chatterjee N; Chanock SJ; Yeager M
    Cancer Epidemiol Biomarkers Prev; 2010 May; 19(5):1349-55. PubMed ID: 20406958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.